腹腔灌注治疗恶性腹水的现状与进展

被引:14
作者
白娟
刘继彦
机构
[1] 四川大学华西医院肿瘤生物科
关键词
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:428 / 429
页数:2
相关论文
共 5 条
[1]
香菇多糖的临床应用进展 [J].
韩玲 .
中国新药杂志, 2001, (02) :88-92
[2]
Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer.[J].Daniele Santini;Cristian Massacesi;Rolando Maria D’Angelillo;Fabiana Marcucci;Costantino Campisi;Bruno Vincenzi;Alberta Pilone;Vincenzo Bianco;Maurizio Bonsignori;Giuseppe Tonini.Medical Oncology.2004, 1
[3]
Immunological inhibition of carcinogenesis [J].
Spadaro, M ;
Lanzardo, S ;
Curcio, C ;
Forni, G ;
Cavallo, F .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (03) :204-216
[4]
Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-α and melphalan [J].
Hohenberger, P ;
Latz, E ;
Kettelhack, C ;
Rezaei, AH ;
Schumann, R ;
Schlag, PM .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (05) :562-568
[5]
Indwelling catheters for the management of malignant ascites.[J].A. Lee;T. N. Lau;K. Y. Yeong.Supportive Care in Cancer.2000, 6